858127C

17:1 Lyso PG

1-(10Z-heptadecenoyl)-sn-glycero-3-phospho-(1′-rac-glycerol) (sodium salt), chloroform

• 同義詞: 1-heptadecenoyl-2-hydroxy-sn-glycero-3-phospho-(1′racglycerol) (sodium salt); PG(17:1(10Z)/0:0); 110712
• 經驗公式（希爾表示法）: C₂₃H₄₄NaO₉P
• CAS號碼: 1246298-11-2
• 分子量：: 518.55
• MDL號碼: MFCD00133433
• 分類程式碼代碼: 51191904
• NACRES: NA.25

屬性

• 化驗: >99% (LPG; may contain up to 10% of the 2-LPG isomer, TLC)
• 形狀: liquid
• 包裝: pkg of 1 × 1 mL (858127C-5mg)
• 製造商／商標名: Avanti Research^™ - A Croda Brand 858127C
• 濃度: 5 mg/mL (858127C-5mg)
• 運輸包裝: dry ice
• 儲存溫度: −20°C

描述

一般說明

Lyso-phospholipids are non bilayer-forming lipids, which are produced in γ-proteobacteria. They are present in normal bacterial membranes.[1]

應用

17:1 Lyso PG has been used as a standard for lipid profiling of rat peritoneal surface layers in liquid chromatography-mass spectrometry (LC-MS) method .[2]

生化／生理作用

Lyso phosphoglycerol (Lyso PG) and acyl-CoA facilitates the synthesis of phosphoglycerol using lysophosphatidylglycerol acyltransferase 1 (LPGAT1).[3] Lysophospholipids exhibits detergent- like physical property.[1]

包裝

5 mL Clear Glass Sealed Ampule (858127C-5mg)

法律資訊

Avanti Research is a trademark of Avanti Polar Lipids, LLC

安全資訊

• 象形圖: GHS06,GHS08
• 訊號詞: Danger
• 危險聲明: H302,H315,H319,H331,H336,H351,H361d,H372,H412
• 防範說明: P201 - P273 - P301 + P312 + P330 - P302 + P352 - P304 + P340 + P311 - P308 + P313
• 危險分類: Acute Tox. 3 Inhalation - Acute Tox. 4 Oral - Aquatic Chronic 3 - Carc. 2 - Eye Irrit. 2 - Repr. 2 - Skin Irrit. 2 - STOT RE 1 - STOT SE 3
• 標靶器官: Central nervous system, Liver,Kidney
• 水污染物質分類（WGK）: WGK 3